Day R - Search Results

1

TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity.

Srour N, Lebel A, McMahon S, Fournier I, Fugère M, Day R, Dubois CM. Srour N, et al. Among authors: day r. FEBS Lett. 2003 Nov 20;554(3):275-83. doi: 10.1016/s0014-5793(03)01159-1. FEBS Lett. 2003. PMID: 14623079 Free article.

2

Processing of proendothelin-1 by members of the subtilisin-like pro-protein convertase family.

Blais V, Fugère M, Denault JB, Klarskov K, Day R, Leduc R. Blais V, et al. Among authors: day r. FEBS Lett. 2002 Jul 31;524(1-3):43-8. doi: 10.1016/s0014-5793(02)02998-8. FEBS Lett. 2002. PMID: 12135739 Free article.

3

Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibition.

Fugère M, Day R. Fugère M, et al. Among authors: day r. Trends Pharmacol Sci. 2005 Jun;26(6):294-301. doi: 10.1016/j.tips.2005.04.006. Trends Pharmacol Sci. 2005. PMID: 15925704 Free PMC article. Review.

4

Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomains.

Fugère M, Limperis PC, Beaulieu-Audy V, Gagnon F, Lavigne P, Klarskov K, Leduc R, Day R. Fugère M, et al. Among authors: day r. J Biol Chem. 2002 Mar 8;277(10):7648-56. doi: 10.1074/jbc.M107467200. Epub 2001 Nov 26. J Biol Chem. 2002. PMID: 11723118 Free article.

5

Inhibitors of the subtilase-like pro-protein convertases (SPCs).

Fugère M, Day R. Fugère M, et al. Among authors: day r. Curr Pharm Des. 2002;8(7):549-62. doi: 10.2174/1381612023395736. Curr Pharm Des. 2002. PMID: 11945158 Review.

6

Lipopolysaccharide mediated regulation of neuroendocrine associated proprotein convertases and neuropeptide precursor processing in the rat spleen.

Lansac G, Dong W, Dubois CM, Benlarbi N, Afonso C, Fournier I, Salzet M, Day R. Lansac G, et al. Among authors: day r. J Neuroimmunol. 2006 Feb;171(1-2):57-71. doi: 10.1016/j.jneuroim.2005.09.019. Epub 2005 Dec 5. J Neuroimmunol. 2006. PMID: 16337011 Free article.

7

Short polybasic peptide sequences are potent inhibitors of PC5/6 and PC7: Use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences.

Fugere M, Appel J, Houghten RA, Lindberg I, Day R. Fugere M, et al. Among authors: day r. Mol Pharmacol. 2007 Jan;71(1):323-32. doi: 10.1124/mol.106.027946. Epub 2006 Sep 29. Mol Pharmacol. 2007. PMID: 17012622

8

The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells.

Levesque C, Fugère M, Kwiatkowska A, Couture F, Desjardins R, Routhier S, Moussette P, Prahl A, Lammek B, Appel JR, Houghten RA, D'Anjou F, Dory YL, Neugebauer W, Day R. Levesque C, et al. Among authors: day r. J Med Chem. 2012 Dec 13;55(23):10501-11. doi: 10.1021/jm3011178. Epub 2012 Nov 14. J Med Chem. 2012. PMID: 23126600 Free PMC article.

9

Molecular Consequences of Proprotein Convertase 1/3 (PC1/3) Inhibition in Macrophages for Application to Cancer Immunotherapy: A Proteomic Study.

Duhamel M, Rodet F, Delhem N, Vanden Abeele F, Kobeissy F, Nataf S, Pays L, Desjardins R, Gagnon H, Wisztorski M, Fournier I, Day R, Salzet M. Duhamel M, et al. Among authors: day r. Mol Cell Proteomics. 2015 Nov;14(11):2857-77. doi: 10.1074/mcp.M115.052480. Epub 2015 Sep 1. Mol Cell Proteomics. 2015. PMID: 26330543 Free PMC article.

10

TGFbeta1 regulates gene expression of its own converting enzyme furin.

Blanchette F, Day R, Dong W, Laprise MH, Dubois CM. Blanchette F, et al. Among authors: day r. J Clin Invest. 1997 Apr 15;99(8):1974-83. doi: 10.1172/JCI119365. J Clin Invest. 1997. PMID: 9109442 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,498 results

Search Page